Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.82 |
| ▸ | PPARG | P37231 | 4/20 | 0.74 |
| ▸ | CTSS | P25774 | 4/20 | 0.66 |
| ▸ | ACE | P12821 | 1/20 | 0.56 |
| ▸ | KLK7 | P49862 | 2/20 | 0.55 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | CTSK | P43235 | 2/20 | 0.52 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.51 |
| ▸ | CDC25B | P30305 | 4/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.51 |
| ▸ | CDC25A | P30304 | 2/20 | 0.51 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.51 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18555200 | 0.95 | PPARA (0.78) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL18555201 | 0.95 | PPARA (0.78) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL1132901 | 0.95 | PPARA (0.90) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL17051 | 0.95 | PPARA (0.90) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL828674 | 0.95 | PPARA (0.90) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL20905468 | 0.91 | PPARA (0.69) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL955526 | 0.90 | PPARA (0.74) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL955527 | 0.90 | PPARA (0.74) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL1312604 | 0.90 | PPARA (0.74) | PPARAPPARGCTSSACEKLK7 | |
| SCHEMBL27586155 | 0.90 | PPARA (0.70) | PPARAPPARGCTSSACEKLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043470-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS | UNIV CORNELL (US) | 2024-02-08 | — | — | US | disclosed |
| US-11834515-B2 | Macrocyclic compounds as proteasome inhibitors | CORNELL UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| EP-3694508-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS | Cornell University (US) | 2020-08-19 | — | — | EP | disclosed |
| WO-2019075259-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS | CORNELL UNIVERSITY (US) | 2019-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043470-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME INHIBITORS | PSMB5, PSMB1, PSMB3 | PPARA 4669/4885PPARG 4428/4885CTSS 640/4885 |
| US-11834515-B2 | Macrocyclic compounds as proteasome inhibitors | PSMB5, PSMB1, PSMB3 | PPARA 4669/4885PPARG 4428/4885CTSS 640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.